Medicare’s ACO Final Rule Responds To Provider Concerns, But Leaves Device Industry Dissatisfied
This article was originally published in The Gray Sheet
Executive SummaryAlthough CMS’ newly finalized rule on accountable care organizations has allayed health care providers’ fears of a program too burdensome to bother with, medical device manufacturers remain worried that ACOs will curb patient access to their products.
You may also be interested in...
CMS principal deputy administrator Andy Slavitt steps in as acting administrator as Marilyn Tavenner plans to depart the agency after five years running the agency. She will leave at the end of February.
Medical device groups worry some that proposed provisions and interpretations in a draft OIG rule could expand exemptions for gainsharing agreements between hospitals and physicians that will hinder the ability of innovative products to gain traction in the market.
Industry group AdvaMed says it is concerned a rapid shift toward pay-for performance and financial risk-sharing models by commercial insurers will discourage providers from giving patients newer devices and could stifle innovation.